Definitive Contract 75N93026C00008
Award Date 7/1/26
Potential Completion Date 6/30/29
Potential Value $4.5M
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Monrovia, CA 91016, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
18
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Chromologic LLC, a minority-owned small business, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) for the "Development of Second-Generation Probiotics as Radiation Mitigators." The $2,709,458.08 cost-plus-fixed-fee contract has a 5-year period of performance through March 2026. The contract supports research and development of advanced therapeutic approaches, including...
- Chromologic LLC, a minority-owned small business located in Monrovia, California, was awarded a $4.88 million cost-plus-fixed-fee contract by the National Institute of Allergy and Infectious Diseases (NIAID) on July 1, 2023, for the development of MIDOS (A MicroRNA Biodosimeter). The contract, which extends through June 30, 2027, responds to NIAID's need for advanced biodosimetry approaches and medical countermeasures to assess and mitigate acute or delayed radiation injuries. The project builds...
- The National Institute of Allergy and Infectious Diseases awarded a $4.5 million definitive contract to Micron Biomedical Inc. for development of radiation and nuclear medical countermeasures and biodosimetry devices on July 1, 2026, with no set-aside. The contract encompasses development of a toll-like receptor 5 agonist dissolving microneedle patch for radiation and nuclear medical applications. Place of performance is Atlanta, Georgia. The period of performance runs from July 1, 2026...
- The National Institute of Allergy and Infectious Diseases awarded a $4.5 million definitive contract to Ceramedix Holding, LLC for development of radiation and nuclear medical countermeasures and biodosimetry devices on July 1, 2026. The contract includes development of CX-03B as a novel medical countermeasure for treatment of gastrointestinal acute radiation syndrome. Place of performance is New York, NY. The contract runs from July 1, 2026 through June 30, 2029 and is priced on a...
- This is a firm-fixed-price Definitive Contract awarded by the U.S. Army Medical Command (MEDCOM) to Chromologic LLC, a minority-owned small business located in Monrovia, California. The contract, valued at $1,099,884.66, is for Chromologic's Phase II SBIR (Small Business Innovation Research) effort on "Radioprotection by JP4-039-MLV Nanoparticle Drugs." The contract is a total small business set-aside and has an ultimate completion date of December 28, 2024. Chromologic is a...
- This federal contract award, valued at $299,914.00, was granted to Chromologic LLC, a minority-owned, for-profit limited liability company, by the National Institute of Allergy and Infectious Diseases, a civilian agency. The contract, which is a Definitive Contract with a Firm Fixed Price pricing type, is for the SBIR 134 - CHROMOLOGIC project. The contract does not have a set-aside designation and has an ultimate completion date of September 24, 2025. Chromologic is a manufacturer of goods that...
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a $6,728,096.00 cost-plus-fixed-fee definitive contract to Myelo Therapeutics GmbH, a for-profit limited liability company, for the development of MYELO001 as an orally applied medical countermeasure to treat hematopoietic acute radiation syndrome. This contract, which has a completion date of January 16, 2025, stems from a Broad Agency Announcement seeking proposals to develop safe and effective medical...
- Chromologic LLC, a minority-owned small business, has been awarded a definitive fixed-price contract valued at $1,498,121 by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases. The contract is for the delivery of mobile health point-of-care diagnostics for malaria, to be performed in Monrovia, California, with work expected to be completed by January 2025. No set-aside designation was used for this award. Through...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract, valued at $224,997.00, was awarded to Chromologic LLC, a minority-owned, for-profit limited liability company, to conduct research and development for the BICER program. The contract has a Firm Fixed Price pricing type and a completion date of September 9, 2016....
- This is a $6,150,127.06 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to BCN Biosciences LLC for the development of medical countermeasures to mitigate and/or treat radiation-induced lung injury after a radiological/nuclear incident. The contract has an ultimate completion date of April 30, 2019 and does not have a set-aside designation. Based on the major program code, this contract supports NIAID's efforts to develop...